Liquid tumours, including acute myeloid leukemia, are life-threatening diseases inducing severe complications that profoundly affect the life of patients and families.
Therapeutic options involve risks, may cause serious complications and may not be definitive.
Alhena Science exploits new advances in identifying tumour-specific targets to develop definitive and curative medicine, devoting all efforts in devising treatment strategies with diligence, competence, efficiency, caution, and honesty, in compliance with health authority and hospital regulations and with highest ethical standards.
Patient resources:
www.cancercare.org
https://bethematch.org/
https://www.lls.org/
https://www.mskcc.org/